Re-review completed for `doi__10.3390_antibiotics8040238`.

Updated the worker-4/worker-6 owned artifacts and closed `rwk-complete-test-0001` as gate-verified. Current status is `accepted_with_cautions`, not clean acceptance.

Key results:
- Database audit: 42 linked DBAASP rows source-reviewed, `source_verified: 42`.
- Final activity/toxicity: expanded to 22 source-supported MIC/MHC/hemolysis rows.
- Final mechanism: replaced pending automated notes with 4 source-reviewed, non-direct computational/SAR claims.
- `quality_feedback.json`: `issue_count: 0`, no open `qc_failure_reasons`, no `rework_targets`.
- `rework_responses.jsonl`: appended repair response and gate-verified closure.
- Workflow/manifest/latest report now show no open rework tickets.

Verification:
- Semantic gate: pass, `issue_count=0`.
  `reports/doi__10.3390_antibiotics8040238.semantic_gate.json`
- Publication QA: pass, `risk_counts={}`.
  `reports/doi__10.3390_antibiotics8040238.publication_quality.json`

Preserved cautions include the absent linked sequence snapshot, DBAASP `ND`/`>250 μM` normalization, the B. cereus strain-label inconsistency, figure-only supplementary DOCX recovery, and no direct wet mechanism claim.

